"First in Man" Total Percutaneous Aortic Arch Repair With 3-Inner-branch Endografts: A Report of Two Cases.

医学 外科 主动脉弓 经皮 动脉瘤 解剖(医学) 主动脉夹层 支架 体外循环 主动脉瘤 放射科
作者
Justine Mougin,Ron Azogui,Julien Guihaire,Mark R Tyrrell,Gustavo S Oderich,Dominique Fabre,Stéphan Haulon
出处
期刊:Annals of Surgery [Lippincott Williams & Wilkins]
卷期号:274 (6): e652-e657
标识
DOI:10.1097/sla.0000000000005167
摘要

Aneurysms of the arch are a complex clinical problem and a technical challenge. Currently, over 40% of patients are considered unfit for conventional open surgery, requiring a cardiopulmonary bypass and hypothermic circulatory arrest. In experienced hands and appropriate anatomic conditions, arch-branched graft technology has shown to be a safe and effective alternative to open conventional surgery to patients that historically have had no surgical options.This report summarizes the first in man implant of a three-vessel arch branch stent graft using a total percutaneous approach without the need for exposure of the cervical arteries-a surgical step with inherent problems and risks.This approach was performed in two consecutive patients, a 66-year-old woman with a chronic post type A dissection 60 mm diameter aneurysm of the aortic arch, and a 72-year-old man with a 70 mm saccular degenerative atheromatous aortic arch aneurysm.Technical success was obtained in both cases. The patients were extubated in the operating theatre. Neither suffered any pre- or postoperative neurological deficits. Both were discharged home after remarkably uneventful hospital stays. There were no access complications. Postoperative computerized tomography scans and ultra-sound confirmed patent supra-aortic branches and completely excluded aneurysms.Our new truly minimally invasive approach demonstrates that it is possible to manage one of the most challenging treatments of aortic pathologies without any surgical incision. Further, evaluation and experience are required to confirm these promising results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
laville完成签到,获得积分10
1秒前
852应助future采纳,获得10
1秒前
风趣的方盒完成签到,获得积分10
1秒前
想发SCI的小钰完成签到,获得积分10
2秒前
3秒前
lmhytr发布了新的文献求助10
4秒前
ldroc完成签到,获得积分10
5秒前
LXN发布了新的文献求助10
6秒前
Lucas应助黄四儿采纳,获得10
7秒前
dsgvdf发布了新的文献求助30
9秒前
10秒前
一二三完成签到,获得积分10
12秒前
13秒前
机智绝悟完成签到,获得积分10
15秒前
ding应助青荣采纳,获得10
15秒前
future发布了新的文献求助10
15秒前
lmhytr完成签到,获得积分10
16秒前
18秒前
酷波er应助饱满的恋风采纳,获得10
20秒前
所所应助天真的热狗采纳,获得10
20秒前
可爱的函函应助lv采纳,获得10
21秒前
大胆的天荷完成签到,获得积分10
22秒前
独特如风关注了科研通微信公众号
22秒前
kbcbwb2002完成签到,获得积分0
24秒前
24秒前
科研通AI2S应助李开心采纳,获得10
25秒前
奶昔完成签到,获得积分10
26秒前
nianhua发布了新的文献求助10
26秒前
星辰大海应助妖精采纳,获得10
27秒前
27秒前
下雨找文献完成签到 ,获得积分10
27秒前
28秒前
orixero应助aa采纳,获得10
28秒前
美好的依琴完成签到,获得积分10
29秒前
天天快乐应助Tony12采纳,获得10
31秒前
31秒前
31秒前
阑已无寻完成签到,获得积分20
33秒前
郭元强完成签到,获得积分10
33秒前
打打应助dsgvdf采纳,获得10
34秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
卤化钙钛矿人工突触的研究 2000
Моделирование процессов самоорганизации в кристаллообразующих системах 1000
History of U.S. Space Surveillance and Satellite Cataloging 1000
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6517739
求助须知:如何正确求助?哪些是违规求助? 8310651
关于积分的说明 17766357
捐赠科研通 5619848
什么是DOI,文献DOI怎么找? 2926089
邀请新用户注册赠送积分活动 1902896
关于科研通互助平台的介绍 1763873